InsiderTrades.com logo
Have you heard of this 5-Day Challenge yet?
From InvestorPlace   |   Ad
You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...
Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go

CDT Insider Trading

Insider Ownership Percentage: 23.49%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,060,881.73

Conduit Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Conduit Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Conduit Pharmaceuticals Share Price & Price History

Current Price: $0.13
Price Change: +0.30 (1.20%)
As of 09/19/2024 01:00 AM ET

This chart shows the closing price history over time for CDT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Have you heard of this 5-Day Challenge yet?
From InvestorPlace   |   Ad
You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...
Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go

Conduit Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/17/2024Andrew ReganDirectorSell1,514,100$0.26$393,666.00177,627View SEC Filing Icon  
7/15/2024Andrew ReganDirectorSell1,005,200$0.25$251,300.0011,936,119View SEC Filing Icon  
7/12/2024Andrew ReganDirectorSell1,389,820$0.25$347,455.0012,941,319View SEC Filing Icon  
7/10/2024Andrew ReganDirectorSell150,000$0.33$49,500.0015,214,091View SEC Filing Icon  
7/8/2024Andrew ReganDirectorSell35,923$0.51$18,320.7315,441,772View SEC Filing Icon  
7/3/2024Andrew ReganDirectorSell1,000$0.64$640.0015,477,695View SEC Filing Icon  
See Full Table
War on Elon Escalates…
From Porter & Company   |   Ad
Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
Click here to learn how you can benefit from its widespread distribution.

SEC Filings (Institutional Ownership Changes) for Conduit Pharmaceuticals (NASDAQ:CDT)

3.29% of Conduit Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Conduit Pharmaceuticals logo
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Read More on Conduit Pharmaceuticals

Today's Range

Now: $0.13
Low: $0.13
High: $0.14

50 Day Range

MA: $0.18
Low: $0.12
High: $0.27

52 Week Range

Now: $0.13
Low: $0.11
High: $22.00

Volume

1,255,205 shs

Average Volume

4,557,714 shs

Market Capitalization

$9.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.11

Who are the company insiders with the largest holdings of Conduit Pharmaceuticals?

Conduit Pharmaceuticals' top insider investors include:
  1. Andrew Regan (Director)
Learn More about top insider investors at Conduit Pharmaceuticals.
Have you heard of this 5-Day Challenge yet?
From InvestorPlace   |   Ad
You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this different from every other options research you may have seen? Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars...
Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go